The importance of a good night's sleep: An open-label trial of the sodium salt of γ-hydroxybutyric acid in insomnia associated with schizophrenia

Schizophrenia Research

Volumn 120, Issue 1-3, 2010, Pages 225-226

  Kantrowitz, Joshua T ^a,b   Oakman, Erin ^a,b   Bickel, Stephan ^a   Citrome, Leslie ^a,b   Spielman, Arthur ^c   Silipo, Gail ^a   Battaglia, Joseph ^d   Javitt, Daniel C ^a  

^a Nathan Kline Institute for Psychiatric Research   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK METHODIST HOSPITAL   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; NEUROLEPTIC AGENT; OXYBATE SODIUM; CENTRAL DEPRESSANT AGENT;

ADJUVANT THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG WITHDRAWAL; EPWORTH SLEEPINESS SCALE; EVENING DOSAGE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INSOMNIA; LETTER; MALE; NAUSEA; NIGHT SLEEP; NOCTURNAL ENURESIS; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP QUALITY; SLEEP TIME; WAKEFULNESS; COMPLICATION; PSYCHOLOGICAL RATING SCALE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

ADJUVANTS, ANESTHESIA; FEMALE; HUMANS; MALE; POLYSOMNOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SLEEP INITIATION AND MAINTENANCE DISORDERS; SODIUM OXYBATE;

EID: 77954145611     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.03.035     Document Type: Letter

References (9)

1. Balla A., Nattini M.E., Sershen H., Lajtha A., Dunlop D.S., Javitt D.C. GABA(B)/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology 2009, 56(5):915-921.
2. Buysse D., Reynolds C., Monk T., Berman S., Kupfer D. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28(2):193-213.
3. Hirshkowitz M. Normal human sleep: an overview. Med. Clin. N. Am. 2004, 88(3):551-565.
4. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14(6):540-545.
5. Kantrowitz J.T., Citrome L., Javitt D.C. GABAB receptors, schizophrenia and sleep dysfunction: a review of the relationship and its clinical and therapeutic implications. CNS Drugs 2009, 23(9):681-691.
6. Kay S., Fiszbein A., Opler L. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
7. Luthringer R., Staner L., Noel N., Muzet M., Gassmann-Mayer C., Talluri K., Cleton A., Eerdekens M., Battisti W.P., Palumbo J.M. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended-release tablets on sleep architecture in patients with schizophrenia. Int. Clin. Psychopharmacol. 2007, 22(5):299-308.
8. Müller M., Rossbach W., Mann K., Röschke J., Müller-Siecheneder F., Blümler M., Wetzel H., Russ H., Dittmann R., Benkert O. Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms. Pharmacopsychiatry 2004, 37(4):157-162.
9. Rechtschaffen A., Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects 1968, Brain Information Service/Brain Research Institute, Los Angeles.